There are well-documented sex differences reported in humans and several AD mice models, where females exhibit a higher risk of developing AD and often present with enhanced neuroinflammatory and Aβ-plaque burden; this finding, therefore, raises possibilities that the decreased AhR expression in female APP/PS1 mice astrocytes may be contributing to the sex-specific vulnerability related to AD pathology. This evidence concerns the gene APP and Alzheimer disease.